Patents
Patents for C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
01/2015
01/20/2015US8937064 Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors
11/2014
11/18/2014US8889741 Cycloalkane derivatives
11/11/2014US8883783 Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
04/2014
04/22/2014US8703763 Bridged piperidine derivatives
03/2014
03/26/2014CN103664924A Preparation method of 3-[(4-amido-2-methyl-5-pyrimidinyl)methyl]-5-(2-chloroethyl)-4-methylthiazol
11/2013
11/21/2013WO2013170656A1 Fluoroethyl thiamine or its salt and application thereof in preparing anticoccidial drugs
05/2013
05/21/2013US8445690 Aminothiazolones as estrogen related receptor-alpha modulators
05/14/2013US8440837 2-substituted-ethynylthiazole derivatives and uses of same
04/2013
04/23/2013US8426604 Aminothiazolones as estrogen related receptor-alpha modulators
11/2012
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
09/2012
09/18/2012US8268816 Compounds for modulating integrin CD11b/CD18
03/2012
03/20/2012US8138191 Inhibitor compounds and cancer treatment methods
02/2012
02/21/2012US8119646 Fungicide hydroximoyl-tetrazole derivatives
02/21/2012US8119645 Fungicide hydroximoyl-tetrazole derivatives
05/2011
05/26/2011WO2010067374A3 Polymorphs of dasatinib
05/24/2011CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors
05/18/2011EP2322535A2 Riboswitches, methods for their use, and compositions for use with riboswitches
05/12/2011US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/2011
03/15/2011US7906516 Carbonyl compounds
12/2010
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
11/2010
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2010124619A1 1,2,3-3h pyridine heterocyclic compounds, their agricultural compositions, their use and their preparation methods
09/2010
09/29/2010EP2233494A1 Riboswitches, methods for their use, and compositions for use with riboswitches
09/07/2010US7790710 Imidazopyridine derivatives useful as iNOS inhibitors
06/2010
06/17/2010WO2010067374A2 Polymorphs of dasatinib
03/2010
03/04/2010US20100056503 Compounds for modulating integrin CD11b/CD18
02/2010
02/25/2010US20100048570 Thiazolidine derivatives and methods for the preparation thereof
01/2010
01/14/2010US20100009969 Fused Oxazoles & Thiazoles As Histamine H3- Receptor Ligands
01/07/2010US20100004254 Therapeutic agents useful for treating pain
12/2009
12/31/2009US20090326008 NF-kappa B Inhibitor
12/17/2009US20090312375 Heterocyclic compounds, compositions comprising them and methods of their use
12/10/2009US20090306156 Phosphodiesterase 4 inhibitors
12/10/2009US20090306073 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers
12/03/2009WO2009144588A2 Riboswitches
11/2009
11/26/2009US20090291992 Androgen receptor-ablative agents
11/26/2009US20090291979 Tricyclic-bridged piperidinylidene derivatives as delta opioid modulators
11/26/2009US20090291969 Fungicide hydroximoyl-tetrazole derivatives
11/12/2009US20090281084 peroxisome proliferator-activated receptor agonists such as 3-{2-Chloro-4-[4-morpholin-4-ylmethyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazol-5-one, suitable for the treatment and/or prevention of neurodegenerative diseases, metabolic and nervous system disorders
10/2009
10/29/2009US20090270466 Epothilones C, D, E, and F, Preparation and Compositions
09/2009
09/24/2009US20090239876 Substituted 4-Hydroxypyrimidine-5-Carboxamides
09/03/2009US20090221574 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors
09/01/2009US7582629 2-tert-butyl-4-[(4-morpholin-4-ylphenyl)amino]-5-phenylisothiazol-3(2H)-one 1,1-dioxide; modulation of nuclear hormone receptors Liver X Receptor; cardiovascular diseases: atherosclerosis; antiinflammatory agent; Alzheimer's disease, antidiabetic agent; insulin resistance, metabolic disorders
07/2009
07/23/2009US20090186869 Antiviral compounds
07/14/2009US7560546 Tyrosine kinase inhibitors
07/09/2009US20090175820 Inhibitors of cytochrome p450
06/2009
06/18/2009WO2009076166A2 Oximyl hcv serine protease inhibitors
06/18/2009US20090156615 Organic compounds
06/18/2009US20090155210 Oximyl hcv serine protease inhibitors
06/11/2009US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide
05/2009
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
04/2009
04/16/2009DE202008016372U1 Vitamin enthaltende Zusammensetzung Vitamin-containing composition
04/02/2009US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides
02/2009
02/25/2009EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors
01/2009
01/22/2009US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity
12/2008
12/02/2008US7459554 Anticancer agent; 1-(3-Benzyloxy-phenyl)-3-cyclobutyl-imidazo[1,5-a]pyrazin-8-ylamine
11/2008
11/20/2008US20080287439 Pyrimidine compounds
11/11/2008US7449461 Benzathiazol-acetamides
09/2008
09/16/2008US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
07/2008
07/17/2008US20080171744 Compounds and method for treatment of cancer
04/2008
04/15/2008US7358359 Antibacterial agents
04/2007
04/17/2007US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis
01/2007
01/16/2007US7163952 Azole compound and medicinal use thereof
01/11/2007US20070010571 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
06/2006
06/21/2006EP1670459A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
01/2006
01/24/2006US6989275 Generating luminescent particles; generate reaction mixture containing biopolymers and cyanine dye, conjugate cyanine dye with biopolymer, evaluate signal from conjugate
07/2005
07/21/2005WO2005018561A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
04/2005
04/14/2005US20050079176 Treating stress response with chemokine receptor ccr5 modulators
03/2005
03/03/2005WO2005018561A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/03/2005CA2536173A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
10/2004
10/27/2004EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators
07/2003
07/31/2003WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators
10/1999
10/06/1999CN1045440C Process for preparing medicinal preparation containing beta-form thiamine hydrochloride crystals
03/1998
03/05/1998WO1998008522A1 Multivitamin products useful in achieving autonomic balance
03/1997
03/26/1997CN1145904A Production of beta-form thiamine hydrochloride crystals
11/1996
11/27/1996CN1033390C Preparation of beta-form thiamine hydrochloride crystals
03/1994
03/01/1994US5290568 Moistening alpha form crystals with water in the presence of beta seed crystals, agitation
03/1993
03/31/1993CN1070401A Production of beta-form thiamine hydrochloride crystals
03/24/1993EP0533103A1 Production of beta-form thiamine hydrochloride crystals
02/1993
02/10/1993CN1068698A Seed treatment
01/1993
01/25/1993CA2074051A1 Seed treatment
11/1989
11/23/1989EP0342482A2 Process for the preparation of pyrimidine derivatives
01/1987
01/20/1987CA1216794A1 Adduct of mutually stabilizing menadione and thiamine
02/1986
02/04/1986US4568745 Animal feeds
12/1985
12/10/1985US4558050 Vitamin b1 dependent enzyme stimulators
01/1984
01/25/1984EP0098995A1 Adduct of mutually stabilizing menadione and thiamine
03/1981
03/17/1981US4256550 Method for producing vitamin B1 and its intermediate
10/1979
10/02/1979CA1063617A1 Fluorodehydroxylation of alcohols
03/1979
03/13/1979US4144342 2-Methyl-3-hydroxy-4-alkanoylthiomethyl-5-vinylpyridines
06/1978
06/20/1978US4096180 Fluorodehydroxylation of serine